These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9882223)

  • 1. Data bases of clinical trials.
    Albrich JM
    N Engl J Med; 1999 Jan; 340(1):65-6. PubMed ID: 9882223
    [No Abstract]   [Full Text] [Related]  

  • 2. [Industry-promoted research and the significance principle].
    Klin Monbl Augenheilkd; 2001 May; 218(5):A90-1. PubMed ID: 11417352
    [No Abstract]   [Full Text] [Related]  

  • 3. [Are treatment effects or adverse effects of significance for the association between financing and conclusions in randomized trials?].
    Als-Nielsen BE; Chen W; Gluud CN; Gluud LL
    Ugeskr Laeger; 2004 Apr; 166(18):1676-8. PubMed ID: 15174406
    [No Abstract]   [Full Text] [Related]  

  • 4. Industry sponsorship and selection of comparators in randomized clinical trials.
    Lathyris DN; Patsopoulos NA; Salanti G; Ioannidis JP
    Eur J Clin Invest; 2010 Feb; 40(2):172-82. PubMed ID: 20050879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Independent research should be supported].
    Als-Nielsen B; Gluud C; Gluud LL
    Ugeskr Laeger; 2003 Oct; 165(44):4237; author reply 4237-8. PubMed ID: 14621563
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceutical company-sponsored drug trials: what are we to believe?
    Shekelle P
    J Clin Epidemiol; 2010 Feb; 63(2):126-7. PubMed ID: 19836207
    [No Abstract]   [Full Text] [Related]  

  • 7. Independent clinical trials.
    Maggio A; D'Amico G; Morabito A
    Lancet; 2004 Mar; 363(9414):1080. PubMed ID: 15051304
    [No Abstract]   [Full Text] [Related]  

  • 8. Disclosure of competing financial interests and role of sponsors in phase III cancer trials.
    Tuech JJ; Moutel G; Pessaux P; Thoma V; Schraub S; Herve C
    Eur J Cancer; 2005 Oct; 41(15):2237-40. PubMed ID: 16214044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How skeptical should we be about industry-sponsored studies?
    Meador KJ
    Neurology; 2007 Apr; 68(15):1238; author reply 1238. PubMed ID: 17420417
    [No Abstract]   [Full Text] [Related]  

  • 10. [Financial interests characterize published reports on coxiber. Whom can we rely on?].
    Håkansson J
    Lakartidningen; 2002 Oct; 99(40):3930-1. PubMed ID: 12422746
    [No Abstract]   [Full Text] [Related]  

  • 11. Medscape psychopharmacology today: understanding clinical trials in context.
    Kramer TA
    MedGenMed; 2003 Oct; 5(4):2. PubMed ID: 14745349
    [No Abstract]   [Full Text] [Related]  

  • 12. [Reflexions on conflicts of interest].
    Canis M
    Gynecol Obstet Fertil; 2010 Jun; 38(6):371-2. PubMed ID: 20576544
    [No Abstract]   [Full Text] [Related]  

  • 13. Advisors may urge NIH to seek out industry support for clinical trials.
    Appel A
    Nature; 1995 Nov; 378(6553):116. PubMed ID: 7477301
    [No Abstract]   [Full Text] [Related]  

  • 14. Large clinical trials in epilepsy: funding by the NIH versus pharmaceutical industry.
    Privitera M
    Epilepsy Res; 2006 Jan; 68(1):52-6. PubMed ID: 16377139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress and problems for randomized clinical trials: from streptomycin to the era of megatrials.
    Hilbrich L; Sleight P
    Eur Heart J; 2006 Sep; 27(18):2158-64. PubMed ID: 16870690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Industry sponsorship in research and publishing: who is really to blame for perceived bias?
    Amsden GW
    Ann Pharmacother; 2004 Apr; 38(4):714-6. PubMed ID: 14982974
    [No Abstract]   [Full Text] [Related]  

  • 17. How clean was the KLEAN trial?
    Bellman P
    Lancet; 2006 Nov; 368(9547):1570-1; author reply 1571. PubMed ID: 17084747
    [No Abstract]   [Full Text] [Related]  

  • 18. Authorship selection in industry-sponsored publications of dermatology clinical trials.
    Tauber M; Paul C
    Br J Dermatol; 2017 Jun; 176(6):1669-1671. PubMed ID: 28303566
    [No Abstract]   [Full Text] [Related]  

  • 19. Policy of the American Society of Gene Therapy on financial conflict ofinterest in clinical research.
    Woo SL
    Mol Ther; 2000 May; 1(5 Pt 1):383-4. PubMed ID: 10979736
    [No Abstract]   [Full Text] [Related]  

  • 20. Conflicts of interest in dermatology.
    Williams HC; Naldi L; Paul C; Vahlquist A; Schroter S; Jobling R
    Acta Derm Venereol; 2006; 86(6):485-97. PubMed ID: 17106594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.